Brain signal analysis software represents a niche product category that caters to a very specific segment of the global medical device industry. They are used for advanced processing and analysis of the raw EEG data that is acquired using EEG machines on patients. As per our report, "Brain Signal Analysis Software Market Outlook to 2017", the market for brain signal analysis software stood at around US$ 30 Million in 2012 and is expected to grow at a double-digit growth rate; higher than the traditional medical device market.

The report contains a detailed analysis of the current scenario of the brain analysis software market and its expected outlook to 2017. The study has defined the market from both, RUO software and software sold for clinical evaluation of diseases. Market breakup by application and expected growth in each segment has been provided.

Various drivers propelling the market growth and challenges faced by the players have been detailed upon in the report. The report also rationally explains the various opportunity areas that a player can explore to boost bottom-line growth. The opportunities have been identified in both the research, as well as clinical diagnosis domain. Besides, the research contains an analysis of the user's expectations from software. The study elucidates on the various parameters that the user evaluates before making a purchase decision.

A detailed analysis of the operations of major players in the industry has also been provided in the study. The study covers their business description, details of their software and a prudent analysis of their strengths and weaknesses.

The report is an outcome of the in-depth analysis of insights generated through interviews with industry leaders and experts. All the data has been collated through various sources to present the most authentic and impartial picture. It is a must buy for any player that wishes to enter or expand in the highly lucrative brain signal analysis software market.

Table Of Contents

1. Analyst View
2. Research Methodology
3. Brain Signal Software Analysis Market to 2017
3.1 Market Overview
3.1.1 Software for Research Laboratory
3.1.2 Software for Clinical Diagnosis and Monitoring
4. Opportunity Assessment
4.1 Polysomnography
4.2 Epilepsy Diagnosis and Treatment
4.3 ADHD Neurofeedback
4.4 Alzheimer’s Disease - Diagnosis and Clinical Trials
4.5 Brain-Computer Interface
5. Competitive Landscape
5.1 Advanced Brain Monitoring
5.1.1 Business Overview
5.1.2 Key Software
5.1.3 Strengths and Weaknesses
5.2 Applied Neuroscience
5.2.1 Business Overview
5.2.2 Key Software
5.2.3 Strengths and Weaknesses
5.3 BESA
5.3.1 Business Overview
5.3.2 Key Software
5.3.3 Strengths and Weaknesses
5.4 Brain Products
5.4.1 Business Overview
5.4.2 Key Software
5.4.3 Strengths and Weaknesses
5.5 Compumedics
5.5.1 Business Overview
5.5.2 Key Software
5.5.3 Strengths and Weaknesses
5.6 Guger Technologies
5.6.1 Business Overview
5.6.2 Key Software
5.6.3 Strengths and Weaknesses
5.7 Natus Medical
5.7.1 Business Overview
5.7.2 Key Software
5.7.3 Strengths and Weaknesses
5.8 Nihon Kohden
5.8.1 Business Overview
5.8.2 Key Software
5.8.3 Strengths and Weaknesses
5.9 Persyst
5.9.1 Business Overview
5.9.2 Key Software
5.9.3 Strengths and Weaknesses
5.10 Source Signal Imaging
5.10.1 Business Overview
5.10.2 Key Software
5.10.3 Strengths and Weaknesses

List of Figures:

Figure 3-1: Brain Signal Analysis Software Market (Million US$), 2012-2017
Figure 3-2: Breakup of Brain Analysis Software Volume by License Ownership (%), 2012
Figure 3-3: Breakup of Brain Analysis Software Volume by End-User (%), 2012
Figure 3-4: Breakup of Brain Analysis Software Volume in Research Laboratories by Application (%), 2012
Figure 3-5: Breakup of Brain Analysis Software Volume in Clinical Laboratories by Application (%), 2012

List of Tables:

Table 4-1: PSG Software Market - Major Players
Table 4-2: Epilepsy EEG Software Market - Major Players
Table 4-3: Neurofeedback EEG Software Market - Major Players
Table 4-4: BCI Software Market - Major Players
Table 5-1: Advanced Brain Monitoring - Key Software
Table 5-2: Advanced Brain Monitoring - Strengths and Weaknesses
Table 5-3: Applied Neuroscience - Key Software
Table 5-4: Applied Neuroscience - Strengths and Weaknesses
Table 5-5: BESA - Key Software
Table 5-6: BESA - Strengths and Weaknesses
Table 5-7: Brain Products - Key Software
Table 5-8: Brain Products - Strengths and Weaknesses
Table 5-9: Compumedics - Strengths and Weaknesses
Table 5-10: Guger Technologies - Strengths and Weaknesses
Table 5-11: Natus Medical - Strengths and Weaknesses
Table 5-12: Nihon Kohden - Strengths and Weaknesses
Table 5-13: Persyst - Strengths and Weaknesses
Table 5-14: Source Signal Imaging - Strengths and Weaknesses

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

  • $ 34 500
  • Industry report
  • July 2014
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 800
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of majo ...

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.